Eli Lilly and Company (NYSE:LLY) is one of the stocks that Jim Cramer shed light on. While Cramer still backed the company, ...

Eli Lilly and Company (NYSE:LLY) is one of the stocks in Jim Cramer’s spotlight. Answering a caller’s query about the company ...

We recently compiled a list of the Jim Cramer’s Lightning Round: 8 Stocks to Watch. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against Jim ...

Novo Nordisk A/S (NYSE:NVO) is one of the stocks that Jim Cramer shed light on. A caller asked about the stock’s status, and ...

We recently compiled a list of the 6 Stocks Jim Cramer Talked About This Week. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other ...

We recently published a list of 10 Jim Cramer Stocks to Watch This Month. In this article, we are going to take a look at where Eli Lilly And Co (NYSE:LLY) stands against other stocks that Jim ...

We recently compiled a list of the Jim Cramer on Nvidia Plus Other Stocks. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stocks ...

We recently compiled a list of the Jim Cramer Discusses These 10 Stocks & Comments On OpenAI’s Valuation. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY ...

Jim Cramer said investors are underestimating the potential impact of a pause in the Eli Lilly coronavirus treatment trial. Skip to main content PREMIUM PRODUCTS ...

CNBC's Jim Cramer on Tuesday explained why he continues to be bullish about pharmaceutical giant Eli Lilly. Continually confident about Eli Lilly because of the enormous success of its weight loss ...

Jim Cramer weighs in on Eli Lilly. Eli Lilly's mixed data from its Alzheimer's drug trial disappointed Wall Street. TheStreet's Martin Baccardax noted that Eli Lilly said that donanemab, an ...

Jim Cramer talked to Eli Lilly's CEO, David Ricks, Tuesday night. And he had some thoughts on the insulin controversy. But first, let's back up. Shares of Eli Lilly are up 81% for the year and ...